Cas:261763-39-7 2,6-Difluoro-3-methylbenzoyl chloride manufacturer & supplier

We serve Chemical Name:2,6-Difluoro-3-methylbenzoyl chloride CAS:261763-39-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2,6-Difluoro-3-methylbenzoyl chloride

Chemical Name:2,6-Difluoro-3-methylbenzoyl chloride
CAS.NO:261763-39-7
Synonyms:2,6-Difluoro-m-toluoyl chloride;MFCD01631334;Benzoyl chloride, 2,6-difluoro-3-methyl-;GVR BF FF C1;2,6-Difluoro-3-methylbenzoyl chloride
Molecular Formula:C8H5ClF2O
Molecular Weight:190.574
HS Code:2916399090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:203.1±35.0 °C at 760 mmHg
Density:1.4±0.1 g/cm3
Index of Refraction:1.500
PSA:17.07000
Exact Mass:189.999695
LogP:1.97

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 3265 8/PG 2
Packing Group:II


Contact us for information like 2,6-Difluoro-m-toluoyl chloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2,6-Difluoro-3-methylbenzoyl chloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,6-Difluoro-3-methylbenzoyl chloride Use and application,MFCD01631334 technical grade,usp/ep/jp grade.


Related News: Flexibility in a CDMO is the key to ensure speed of tech-transfer which is a true litmus test for CDMOs which can help a company chose between competing analytical strategies, manufacturing technology and knowledge for improving productivity. Chaetominine manufacturers “The approval of Verquvo in the EU will provide doctors, health care professionals and patients with an important treatment option to complement currently available heart failure therapies,” he added. N’-quinolin-4-ylpropane-1,3-diamine suppliers “This announcement reflects another important regulatory milestone in the development of this medicine,” said Roy Baynes, senior vice president and head of global clinical development, chief medical officer, Merck Research Laboratories. (3R)-3-Amino-1-ethyl-2-azepanone vendor & factory.